Global Wound Management Technologies Driving $22.4 Billion Market by 2024 According to New MedMarket Diligence Report

FOOTHILL RANCH, Calif. - Dec. 29, 2015 - PRLog -- Surgical incisions, trauma, lacerations, ulcers, burns, and other acute and chronic wounds are faced with a litany of technologies designed to better manage wounds by doing so more rapidly, more clinically effective, less expensively, or all of the above. These technologies span simple gauze and adhesive dressings, to dressings integrated with or comprised of many different components, to physical systems like negative pressure wound therapy (NPWT) and biologically derived skin replacements, growth factors and others. These technologies have penetrated markets worldwide and exhibit variable adoption driven by local demand. The products, technologies, companies, and markets in wound management are the subject of the 2015 MedMarket Diligence report, “Worldwide Wound Management, Forecast to 2024: Established and Emerging Products, Technologies and Markets in the Americas, Europe, Asia/Pacific and Rest of World.”

“Few medtech markets pose the competitive challenges for a wound management product, at least in terms of the number and diversity of potential competitors. There is indeed enormous normous caseload (upwards of 100 million surgical incisions alone are made each year) but the need for many alternative treatment has driven the development of many innovations in a market where there are few barriers to entry, resulting challenges for manufacturers to gauge the competitive landscape,” says Patrick Driscoll of MedMarket Diligence, LLC.

Growth in wound management product sales is arising to a significant degree from biotech developments. Bioengineered skin, skin substitutes, and wound-related growth factors are gaining new caseloads from penetrating acute and chronic wound markets. However, more staid technologies like foam dressings, hydrocolloids, and alginates are showing strong growth on substantial volume. Equally important, the growth of wound management worldwide reflects migration of technologies from developed to developing markets, creating incentives for medtech to reach OUS markets.

The MedMarket Diligence Report, “Worldwide Wound Management, Forecast to 2024: Established and Emerging Products, Technologies and Markets in the Americas, Europe, Asia/Pacific and Rest of World” report details the complete range of products and technologies used in wound management and wound care, from dressings, bandages, hydrogels, tissue engineered products, physical treatments and others. The report will detail current clinical and technology developments in the worldwide market providing a current assessment of products in development and on the market; market size and forecast; competitor market shares; key competitor profiles; and an assessment of the market opportunity for current and hopeful competitors.

The report provides year (at least three fiscal quarters actual) 2015 market size and share data, with forecast market data to 2024, for the Americas (with detail for U.S., Rest of North America and Latin America), Europe (with detail for United Kingdom, Germany, France, Spain, Italy, and Rest of Europe), Asia/Pacific (with detail for Japan, Korea, and Rest of Asia/Pacific) and Rest of World.

This report details the current and projected market for wound management products, including dressings, closure devices, debridement, pharmacological products, tissue engineered products and others. The emphasis of analysis is on advanced and leading edge developments (i.e., those approaching wound management from novel perspective) such as growth factors, stem cells, gene therapy and other approaches, while baseline data (current and forecast market size and current competitor market shares per country) is provided for established segments -- multiple dressing types (film, foam, alginate, antibacterial, non-adherent), hydrogels, hydrocolloids, and physical treatments. The report details the clinical and technology developments underlying the clinical practice and market development in wound care market, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity. Separate size, growth and competitor data are presented for the U.S., rest of North America, Latin America, leading western European countries (specifically, United Kingdom, Germany, France, Italy, Spain), rest of Europe, Japan, Korea, rest of Asia/Pacific, and the Rest of World category. The report’s company profiles assess leading and key emerging companies regarding current/projected products, technologies and positions in the advanced wound care market.

The report is detailed in full, with complete table of contents and list of exhibits, at http://mediligence.com/rpt/rpt-s251.htm.

The report may be purchased for download from https://www.mediligence.com/store/page53.html.

For coverage of the related market, Surgical Sealants, Glues, and Wound Closure, see the MedMarket Diligence report #S192, “Worldwide Market for Surgical Sealants, Glues, and Wound Closure, 2013-2018”. See http://mediligence.com/rpt/rpt-s192.htm.